Records containing: Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-03-12Neoadjuvant Therapy for Locally Advanced Esophageal Cancer: Impact on Cardiopulmonary Physiology, Short- and Long-term Morbidity
-
CLINICAL_TRIALS study record update · 2018-02-20Phenotype of Pulmonary Fibrosis Associated With a Mutation of Telomerase
-
CLINICAL_TRIALS study record update · 2018-02-08Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation
-
CLINICAL_TRIALS study record update · 2017-07-02Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Identification of Genetic Polymorphisms
-
CLINICAL_TRIALS study record update · 2017-07-02Specimen Procurement for Individuals With Pulmonary Fibrosis Associated With Rheumatoid Arthritis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-06Translation Into Spanish of an Interstitial Lung Disease Quality of Life Questionnaire (KBILD)
-
CLINICAL_TRIALS study record update · 2017-04-04A Phase 1b, Multicenter, Open-label, Staggered-dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of CC-90001 for 3 Months in Patients With Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-03-06A Phase II Open Label, Follow up Study to Investigate the Long Term Tolerability and Safety of Oral BIBF 1120 on Top of Pirfenidone in Japanese Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-07-29Sildenafil Treatment in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension - a Pilot Cross-over Study
-
CLINICAL_TRIALS study record update · 2016-07-12ClinicalTrials.gov study NCT00005317
-
CLINICAL_TRIALS study record update · 2016-03-16Pilot Investigation on the Combined Use of Established Clinical Criteria and Systems Biology for Progressive Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-03-09An Open-Label, Phase 2 Study of the Safety of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-02-18ClinicalTrials.gov study NCT00016627
-
CLINICAL_TRIALS study record update · 2016-02-09Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-01-29Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis Normoxemic at Rest Who Desaturate on Exercise
-
CLINICAL_TRIALS study record update · 2015-12-28A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 888 Administered Intravenously in Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2015-07-14Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment
-
CLINICAL_TRIALS study record update · 2015-06-02Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF
-
CLINICAL_TRIALS study record update · 2015-03-06Cyclophosphamide Versus Placebo in Scleroderma Lung Study
-
CLINICAL_TRIALS study record update · 2015-03-05Idiopathic Pulmonary Fibrosis International Group Exploring NAC I Annual Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2015-02-13A 52 Weeks, Double Blind, Randomized, Placebo-controlled Trial Evaluating the Effect of Oral BIBF 1120, 150 mg Twice Daily, on Annual Forced Vital Capacity Decline, in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2015-02-13A 52 Weeks, Double Blind, Randomized, Placebo-controlled Trial Evaluating the Effect of Oral BIBF 1120, 150 mg Twice Daily, on Annual Forced Vital Capacity Decline, in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2015-01-06A 12 Month, Double Blind, Randomized, Placebo-controlled Trial Evaluating the Effect of BIBF 1120 Administered at Oral Doses of 50 mg qd, 50 mg Bid, 100 mg Bid and 150 mg Bid on Forced Vital Capacity Decline During One Year, in Patients With Idiopathic Pulmonary Fibrosis, With Optional Active Treatment Extension Until Last Patient Out.
-
CLINICAL_TRIALS study record update · 2014-07-25Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
-
CLINICAL_TRIALS study record update · 2014-03-26The Influence of Personality on Quality of Life, Fatigue, Prognosis, and Health Care Consumption in Pulmonary Fibrosis and Sarcoidosis